ARTICLE | Company News
Hanmi Pharmaceutical, SK Biopharmaceuticals deal
May 7, 2012 7:00 AM UTC
SK Biopharmaceuticals granted Hanmi rights to market diazepam nasal spray in China and Korea. SK will receive an undisclosed upfront payment, and will be eligible for undisclosed milestones and royal...